Skip to main content
Year archive

IDT AUSTRALIA LIMITED — 2016 filings

All 35 regulatory filings released by IDT AUSTRALIA LIMITED (IDT) in 2016, sourced directly from the official regulator.

35 Filings
2016 Period
2016 filings (35)
Filing Released Lang
Change in substantial holding 2 pages 136.1KB
Regulatory Filings
2016-12-20 English
Completion of Initial CMAX Transaction 2 pages 186.9KB
Capital/Financing Update
2016-12-14 English
Mayne Pharma Announces U.S. Launch of IDT's Temozolomide 2 pages 539.6KB
Regulatory Filings
2016-11-21 English
1st generic proprietary product shipped to US, temozolomide 2 pages 132.8KB
Regulatory Filings
2016-11-01 English
IDT Divests CMAX Clinical Trial Business to I'rom Group 2 pages 458.6KB
Capital/Financing Update
2016-10-27 English
Trading halt 2 pages 386.6KB
Regulatory Filings
2016-10-25 English
Appendix 3B 12 pages 118.9KB
Capital/Financing Update
2016-10-20 English
Director Resignation 1 page 145.8KB
Board/Management Information
2016-10-17 English
Results of Meeting 2 pages 42.5KB
Declaration of Voting Results & Voting Rights Announcements
2016-10-17 English
Investor Presentation, AGM 17 October 2016 19 pages 476.1KB
Investor Presentation
2016-10-16 English
Receives Export Award, Health and Biotechnology 2 pages 150.1KB
Regulatory Filings
2016-10-06 English
Appendix 3B 12 pages 118.0KB
Capital/Financing Update
2016-09-20 English
Cancellation of shares 3 pages 103.1KB
Regulatory Filings
2016-09-20 English
Notice of Annual General Meeting/Proxy Form 23 pages 1.3MB
AGM Information
2016-09-15 English
Awarded Future Industries Manufacturing Program Grant 2 pages 153.3KB
Capital/Financing Update
2016-09-05 English
Appendix 4G 11 pages 89.3KB
Regulatory Filings
2016-08-24 English
Appendix 4E 13 pages 156.7KB
Annual Report
2016-08-23 English
Full Year Statutory Accounts 36 pages 402.4KB
Annual Report
2016-08-23 English
Appendix 3B 12 pages 509.1KB
Regulatory Filings
2016-08-02 English
Appendix 3B 12 pages 516.4KB
Regulatory Filings
2016-07-05 English
Cleansing Notice 1 page 70.1KB
Regulatory Filings
2016-07-05 English
Becoming a substantial holder 2 pages 125.3KB
Regulatory Filings
2016-06-30 English
Completion of private placement 2 pages 152.3KB
Capital/Financing Update
2016-06-29 English
Trading Halt 2 pages 276.5KB
Regulatory Filings
2016-06-27 English
Updated Investor Presentation 22 pages 681.9KB
Interim / Quarterly Report
2016-06-26 English
Ceasing to be a substantial holder 3 pages 60.9KB
Regulatory Filings
2016-06-07 English
CMAX - Opening of new Clinical Trial Facility 2 pages 95.6KB
Regulatory Filings
2016-05-01 English
Updated Investor Presentation 19 pages 2.4MB
Regulatory Filings
2016-04-13 English
FDA Approval for Temozolomide 2 pages 152.1KB
Regulatory Filings
2016-04-12 English
Manufacturing partner appointed 2 pages 131.0KB
Capital/Financing Update
2016-03-29 English
Thiotepa - Contract Extension and Revenues 2 pages 151.5KB
Capital/Financing Update
2016-03-08 English
Appendix 4D 4 pages 22.0KB
Interim / Quarterly Report
2016-02-18 English
Half Yearly Report and Accounts 16 pages 1.1MB
Regulatory Filings
2016-02-18 English
Ceasing to be a substantial holder 5 pages 60.3KB
Regulatory Filings
2016-02-14 English
Becoming a substantial holder 5 pages 94.2KB
Regulatory Filings
2016-01-04 English